TY - JOUR
T1 - An open trial of vacuum penile tumescence
T2 - Constriction therapy for neurological impotence
AU - Heller, L.
AU - Keren, O.
AU - Aloni, R.
AU - Davidoff, G.
N1 - Funding Information:
This study was supported by a research training grant by the National Institute on Disability and Rehabilitation Research, US Department of Education, Washington, DC (H133-P80037), and the US-Israel Educational Foundation, Tel Aviv, IsraeL
PY - 1992/8
Y1 - 1992/8
N2 - Sexual dysfunction is a frequent result of traumatic and non traumatic neurological disorders, including spinal cord injury, stroke, traumatic brain injury and autonomic neuropathy (for example, as may be seen in patients with diabetes mellitus). Although many methods have been suggested for the treatment of some of these problems in male patients, most are invasive and have a substantial morbidity. This is the report of a pilot trial of vacuum tumescence constriction therapy for 30 patients with chronic neurological impotence. Seventeen of these patients, following sexual counselling and training, decided to purchase such a device. At follow up, a mean of 21 months, over 50% of those who had purchased the device were still actively using it. The frequency of coitus increased from 0.3/wk to 1.5/wk (t = -5.7; p < 0.0001). No significant morbidity was reported by patients. Vacuum tumescence constriction therapy shows promise as a noninvasive method for the treatment of neurological impotence.
AB - Sexual dysfunction is a frequent result of traumatic and non traumatic neurological disorders, including spinal cord injury, stroke, traumatic brain injury and autonomic neuropathy (for example, as may be seen in patients with diabetes mellitus). Although many methods have been suggested for the treatment of some of these problems in male patients, most are invasive and have a substantial morbidity. This is the report of a pilot trial of vacuum tumescence constriction therapy for 30 patients with chronic neurological impotence. Seventeen of these patients, following sexual counselling and training, decided to purchase such a device. At follow up, a mean of 21 months, over 50% of those who had purchased the device were still actively using it. The frequency of coitus increased from 0.3/wk to 1.5/wk (t = -5.7; p < 0.0001). No significant morbidity was reported by patients. Vacuum tumescence constriction therapy shows promise as a noninvasive method for the treatment of neurological impotence.
KW - Male neurological impotence
KW - Vacuum penile constriction tumescence
UR - http://www.scopus.com/inward/record.url?scp=0026763221&partnerID=8YFLogxK
U2 - 10.1038/sc.1992.113
DO - 10.1038/sc.1992.113
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 1522995
AN - SCOPUS:0026763221
SN - 0031-1758
VL - 30
SP - 550
EP - 553
JO - Paraplegia
JF - Paraplegia
IS - 8
ER -
